https://www.selleckchem.com/ph....armacological_epigen
57 (95% CI, 1.05-6.30; P=0.039). Patients with a good LIPI score had a longer survival compared with those with intermediate/poor scores, with an estimated median OS of 10.4 vs. 3.9 months (HR=2.59, 95% CI 1.69-3.98) and a median PFS of 7.7vs. 2.1 months (HR=2.95, 95% CI1.91-4.56). Multivariate analysis indicated that the intermediate/poor LIPI was independently associated with OS (HR 2.32, 95% CI 1.44-3.72) and PFS (HR 2.48, 95% CI 1.53-4.03). These data are the first to suggest that the pretreatment LIPI was well correlated
Like
Comment
Share
